LENZ Therapeutics (LENZ) Other Non Operating Income (2021 - 2026)
LENZ Therapeutics (LENZ) reported Other Non Operating Income of $3000.0 for Q1 2026, up 127.27% year-over-year from $1320.0 in Q1 2025, and up 100.72% on a QoQ basis from -$417000.0 in Q4 2025.
LENZ Therapeutics (LENZ) has 6 years of Other Non Operating Income data on file, last reported at $3000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 127.27% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$229000.0 (down 114.08% YoY) and the FY2025 annual result came in at -$243000.0, down 184.08% from the prior year.
- Other Non Operating Income improved to $3000.0 in Q1 2026 per LENZ's latest filing, from -$417000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.2 million in Q4 2022 and bottomed at -$1.3 million in Q1 2024.
- The 5-year median for Other Non Operating Income is $3000.0 (2026), against an average of $278235.3.
- The widest annual swing landed in 2022, when Other Non Operating Income soared 21420.0%; it then tumbled 5312.5% in 2025.
- Tracing LENZ's Other Non Operating Income over 5 years: stood at $2.2 million in 2022, then sank by 87.59% to $267000.0 in 2023, then tumbled by 97.0% to $8000.0 in 2024, then plunged by 5312.5% to -$417000.0 in 2025, then soared by 100.72% to $3000.0 in 2026.
- Per Business Quant, the three latest LENZ Other Non Operating Income figures stand at $3000.0 (Q1 2026), -$417000.0 (Q4 2025), and -$14000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | -417,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | -1.35 Mn |
| Dec 31, 2023 | 267,000.00 |
| Sep 30, 2023 | -101,000.00 |
| Jun 30, 2023 | -18,000.00 |
| Mar 31, 2023 | -54,000.00 |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 840,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 4,000.00 |